Published September 29, 2006 | Version v1
Journal article

Allele-specific MMP-3 transcription under in vivo conditions

  • 1. Atherosclerosis Research Unit, King Gustav V Research Institute, Department of Medicine, Karolinska Institute, Stockholm (Sweden)
  • 2. Department of Biotechnology, AlbaNova University Center, Royal Institute of Technology, Stockholm (Sweden)

Description

A common matrix metalloproteinases-3 (MMP-3) -1612 5A/6A promoter polymorphism is associated with risk for cardiovascular disease, rheumatoid arthritis, and other diseases. Here we used the haplotype chromatin immunoprecipitation method to study allele-specific MMP-3 expression under in vivo conditions in heterozygous THP-1 cells. Pyrosequencing was used to analyse the ratio of 5A-allele to 6A-allele after chromatin immunoprecipitation using an antibody against phosphorylated active RNA polymerase II. There was no allele-specific difference in transcriptional activity during basal conditions, i.e., in unstimulated monocytic THP-1 cells. However, after stimulation of MMP-3 expression by monocyte differentiation or incubation with IL-1β, the haplotype containing the 5A-allele was associated with higher transcriptional activity compared with the 6A-containing haplotype. Electromobility shift assay demonstrated increased binding of nuclear proteins to the 5A-allele after monocyte differentiation. In conclusion, the common MMP-3 5A/6A promoter polymorphism appears to be functional only during specific environmental conditions involving inflammation

Additional details

Identifiers

DOI
10.1016/j.bbrc.2006.07.174;
PII
S0006-291X(06)01752-9;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
348
Journal Issue
3
Journal Page Range
p. 1150-1156
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
38027483
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ANTIBODIES; CARDIOVASCULAR DISEASES; CHROMATIN; HAZARDS; IN VIVO; INCUBATION; INFLAMMATION; MONOCYTES; PROMOTERS; PROTEINS; RHEUMATIC DISEASES; RNA; STIMULATION; TRANSCRIPTION
Descriptors DEC
BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY FLUIDS; DISEASES; LEUKOCYTES; MATERIALS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; PATHOLOGICAL CHANGES; SYMPTOMS

Optional Information

Copyright
Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.